RevenueWell receives growth equity investment from Marlin


Revenue Well Systems, LLC (“RevenueWell”) is pleased to announce that it has received a growth equity investment from Marlin Equity Partners (“Marlin”), a global investment firm with a strong history of successfully investing in and growing businesses across the software and healthcare verticals. The investment by Marlin allows RevenueWell to further build upon the company’s strong product portfolio and continue to help dental and healthcare organizations thrive and deliver high quality care through software.

“RevenueWell has become a trusted partner to dental practices, dental support organizations and other healthcare practices seeking to attract, retain and maximize the lifetime value of every patient across their practice,” said Serge Longin, co-founder of RevenueWell. “We are excited to partner with Marlin and leverage their operational expertise to execute our shared strategic vision to accelerate growth and better serve our customers by addressing their most pressing practice growth and management needs.”

“Marlin recognizes our position as the leading patient relationship software provider for dental and healthcare practices” said Alex Nozdrin, co-founder of RevenueWell. “We are enthusiastic to find a like-minded partner best positioned to help us embark on our next chapter of growth.”

“RevenueWell helps dental practices maximize production and boost profitability” said Max Longin, co-founder of RevenueWell. “We look forward to working with Marlin to expand and enhance our current product portfolio to tightly integrate healthcare practice success and patient care.”

“We are thrilled to add RevenueWell to our portfolio of growth oriented technology businesses and further advance the company’s vision of helping healthcare practices grow by utilizing the company’s best-in-class technology and services” said Nick Lukens, a principal at Marlin. “We are committed to partnering with RevenueWell to further accelerate growth and support their efforts in expanding their product offering.”

Financial details of the transaction have not been disclosed. AGC Partners acted as financial advisor and Massumi + Consoli LLP served as legal advisor to Marlin Equity Partners. Vaquero Capital LLC acted as financial advisor and Foley & Lardner LLP served as legal advisor to RevenueWell.

About Marlin Equity Partners

Marlin Equity Partners is a global investment firm with over $6.7 billion of capital under management. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company’s outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 160 acquisitions. The firm is headquartered in Los Angeles, California with an additional office in London. For more information, please visit http://www.marlinequity.com.

About RevenueWell

Founded in 2010, RevenueWell enables dental practices to manage patient engagement, patient relationships, online practice reputation and appointment reminders. The company also offers desktop two-way texting, VoIP phones, electronic patient intake forms and an enterprise management dashboard that allows group practices and dental service organizations to manage their portfolios. RevenueWell’s product suite and integration with the leading practice management software providers help reduce manual labor by automating and facilitating patient contact and patient interactions, which lead to strong ROI for its dental office customers. The company is headquartered in Chicago, Illinois. For more information, please visit http://www.RevenueWell.com.

For additional information, please contact Peter Spasov at (310) 364-0100 or via e-mail at pspasov@marlinequity.com.

Share article on social media or email:

Leave a Reply